{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-044830","form_type":"8-K","ticker":"SER","cik":"0001708599","company_name":"Serina Therapeutics, Inc.","filed_at":"2024-11-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.300858+00:00","generated_at":"2026-05-30T02:02:35.650349+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"Serina Therapeutics reports Q3 net income of $1.4M but raises going concern doubt as cash stands at $3.2M","bullets":["Net income $1.4M ($0.16 basic EPS) vs $1.8M a year ago; revenue $14k from NIH grants.","Operating expenses surged to $5.3M from $1.5M, driven by R&D and G&A increases.","Cash, cash equivalents, and restricted cash $3.2M; company expects insufficient funds for 12 months.","Expects ~$10M from Juvenescence warrant exercise via side letter, but still substantial doubt about going concern.","Lead candidate SER-252 (apomorphine) for Parkinson's planned for clinical testing in 2025; partnership with Enable Injections."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-044830","json":"https://secwatch.observer/filing/0001493152-24-044830.json","markdown":"https://secwatch.observer/filing/0001493152-24-044830.md","text":"https://secwatch.observer/filing/0001493152-24-044830.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1708599/000149315224044830/0001493152-24-044830-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1708599/000149315224044830/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T02:02:35.650349+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}